Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study

J Am Acad Dermatol. 2016 Nov;75(5):1068-1071. doi: 10.1016/j.jaad.2016.06.040.

Authors

Affiliations

¹ University of Vermont College of Medicine, Burlington. Electronic address: Benjamin.Farahnik@med.uvm.edu.
² University of California Los Angeles, David Geffen School of Medicine, Los Angeles.
³ University of California San Francisco, School of Medicine.
⁴ University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center.
⁵ University of California Irvine, School of Medicine.
⁶ University of Southern California Keck School of Medicine, Los Angeles.

PMID: 27745637
DOI: 10.1016/j.jaad.2016.06.040

No abstract available

MeSH terms

Administration, Cutaneous
Adrenal Cortex Hormones / administration & dosage
Adrenal Cortex Hormones / therapeutic use*
Adult
Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / therapeutic use*
Antipruritics / administration & dosage
Antipruritics / therapeutic use
Coal Tar / administration & dosage
Coal Tar / therapeutic use*
Combined Modality Therapy
Dermatitis, Atopic / drug therapy
Dermatitis, Atopic / radiotherapy*
Female
Humans
Keratolytic Agents / administration & dosage
Keratolytic Agents / therapeutic use*
Male
Pilot Projects
Prospective Studies
Severity of Illness Index
Treatment Outcome
Ultraviolet Therapy / methods*

Substances

Adrenal Cortex Hormones
Anti-Inflammatory Agents
Antipruritics
Keratolytic Agents
Coal Tar